INMED PHARMACEUTICALS INC (INM) Stock Analyst Ratings

NASDAQ:INM • CA4576377002

0.86 USD
0 (0%)
Last: Feb 20, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

45

ChartMill assigns a Buy % Consensus number of 45% to INM. The Buy consensus is the weighted average rating of the current analysts ratings.

  • INM was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about INM.
  • In the previous month the buy percentage consensus was at a similar level.
  • INM was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
INM Historical Analyst RatingsINM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
INM Current Analyst RatingINM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2021-11-29 HC Wainwright & Co. Initiate Buy
2021-02-16 Roth Capital Maintains Buy

INMED PHARMACEUTICALS INC / INM FAQ

What is the consensus rating for INM stock?

The consensus rating for INMED PHARMACEUTICALS INC (INM) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


Can you provide the analyst count for INMED PHARMACEUTICALS INC stock?

The number of analysts covering INMED PHARMACEUTICALS INC (INM) is 8.